The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the electroceuticals market, by product segment, in 2022 Based on product, the ...

Global Bioelectric Medicine Market to Reach $29,125.8 Million by 2025 Key Questions Answered in this Report: Read the full report: https://www.reportlinker.com ...

Bioelectric medicine, a burgeoning field at the intersection of biology, electronics, and healthcare, holds immense promise in revolutionizing the treatment landscape for a myriad of medical ...

LOS ANGELES, Jan. 8, 2026 /PRNewswire/ -- Electrome Corporation, a unique biotech company developing next-generation ...

Increasing prevalence of chronic diseases, advancements in technology, and rising demand for non-invasive therapies drive the growth of the global electroceuticals ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that a scientific ...

Sarcopenia affects up to 16% of the world’s aging population and is one of the leading factors in the loss of independence. Marked by a loss of both muscle mass and function or strength, it’s behind ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...